News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,791 Results
Type
Article (40362)
Company Profile (259)
Press Release (665170)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (206197)
Career Advice (2029)
Deals (35835)
Drug Delivery (95)
Drug Development (81517)
Employer Resources (173)
FDA (16262)
Job Trends (15022)
News (348192)
Policy (32840)
Tag
Academia (2585)
Accelerated approval (5)
Adcomms (21)
Allergies (86)
Alliances (49871)
ALS (94)
Alzheimer's disease (1392)
Antibody-drug conjugate (ADC) (139)
Approvals (16256)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (16)
Bankruptcy (364)
Best Places to Work (11783)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (185)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (290)
Cancer (2320)
Cardiovascular disease (180)
Career advice (1694)
Career pathing (30)
CAR-T (155)
Cell therapy (434)
Cervical cancer (20)
Clinical research (66399)
Collaboration (861)
Company closure (2)
Compensation (557)
Complete response letters (19)
COVID-19 (2619)
CRISPR (41)
C-suite (251)
Cystic fibrosis (102)
Data (2305)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6476)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (102)
Drug shortages (25)
Duchenne muscular dystrophy (96)
Earnings (88187)
Editorial (39)
Employer branding (22)
Employer resources (147)
Events (114266)
Executive appointments (739)
FDA (17626)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (771)
Gene editing (110)
Generative AI (20)
Gene therapy (314)
GLP-1 (719)
Government (4463)
Grass and pollen (4)
Guidances (150)
Healthcare (19114)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (123)
Indications (29)
Infectious disease (2764)
Inflammatory bowel disease (145)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (97)
Interviews (318)
IPO (16827)
IRA (40)
Job creations (3649)
Job search strategy (1436)
Kidney cancer (10)
Labor market (43)
Layoffs (477)
Leadership (17)
Legal (7975)
Liver cancer (76)
Lung cancer (327)
Lymphoma (158)
Machine learning (9)
Management (58)
Manufacturing (322)
MASH (74)
Medical device (13564)
Medtech (13569)
Mergers & acquisitions (19572)
Metabolic disorders (707)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (28)
Neuroscience (1942)
NextGen: Class of 2025 (6564)
Non-profit (4495)
Now hiring (40)
Obesity (373)
Opinion (208)
Ovarian cancer (81)
Pain (93)
Pancreatic cancer (88)
Parkinson's disease (150)
Partnered (21)
Patents (241)
Patient recruitment (115)
Peanut (46)
People (57648)
Pharmaceutical (63)
Pharmacy benefit managers (19)
Phase I (20721)
Phase II (29251)
Phase III (21759)
Pipeline (1346)
Policy (148)
Postmarket research (2570)
Preclinical (8807)
Press Release (66)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (389)
Real estate (5937)
Recruiting (65)
Regulatory (22531)
Reports (47)
Research institute (2343)
Resumes & cover letters (351)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (70)
Series A (133)
Series B (88)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (149)
Sponsored (29)
Startups (3598)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (48)
The Weekly (30)
Vaccines (704)
Venture capitalists (42)
Weight loss (240)
Women's health (36)
Worklife (16)
Date
Today (6)
Last 7 days (933)
Last 30 days (2947)
Last 365 days (32514)
2025 (11729)
2024 (35507)
2023 (40574)
2022 (51760)
2021 (56423)
2020 (54776)
2019 (47234)
2018 (35475)
2017 (32396)
2016 (31686)
2015 (37728)
2014 (31496)
2013 (26499)
2012 (28693)
2011 (29428)
2010 (27442)
Location
Africa (721)
Alabama (59)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (38538)
Australia (6280)
California (6383)
Canada (2065)
China (543)
Colorado (272)
Connecticut (279)
Delaware (158)
Europe (83245)
Florida (946)
Georgia (212)
Idaho (58)
Illinois (548)
India (25)
Indiana (320)
Iowa (11)
Japan (171)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (69)
Maryland (932)
Massachusetts (4749)
Michigan (235)
Minnesota (412)
Mississippi (2)
Missouri (85)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (64)
New Jersey (1788)
New Mexico (28)
New York (1796)
North Carolina (990)
North Dakota (8)
Northern California (2808)
Ohio (208)
Oklahoma (14)
Oregon (34)
Pennsylvania (1430)
Puerto Rico (13)
Rhode Island (33)
South America (1117)
South Carolina (25)
South Dakota (1)
Southern California (2401)
Tennessee (106)
Texas (947)
United States (23992)
Utah (188)
Virginia (154)
Washington D.C. (64)
Washington State (564)
West Virginia (3)
Wisconsin (59)
705,791 Results for "code biotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Press Releases
CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code for Otulfi® (ustekinumab-aauz)
April 29, 2025
·
11 min read
Press Releases
New ICD-10 Codes Recognize Fontan-Associated Conditions, Advancing Care and Coverage for Rare Congenital Heart Disease Community
April 17, 2025
·
2 min read
Press Releases
TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping
March 27, 2025
·
5 min read
Antibody-drug conjugate (ADC)
Roche Ups ADC Bet With $1B in Biobucks for Oxford BioTherapeutics
Roche’s up to $1 billion investment will provide access to Oxford BioTherapeutics’ antibody-drug conjugate platform for undisclosed cancer targets.
March 19, 2025
·
1 min read
·
Tristan Manalac
Pharm Country
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
Helius Medical Technologies, Inc. announced that the Centers for Medicare & Medicaid Services has assigned Healthcare Common Procedure Coding System Level II codes A4593, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime” to describe the PoNS controller and A4594, “Neuromodulation stimulator system, adjunct to rehabilitation therapy regime, mouthpiece each” to describe the PoNS mouthpiece.
March 4, 2024
·
7 min read
Genetown
Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S. Centers for Medicare & Medicaid Services (CMS) Covering PEMGARDA™
Invivyd, Inc. announced that the U.S. Centers for Medicare & Medicaid Services has granted a Healthcare Common Procedure Coding System Q code covering product reimbursement for PEMGARDA.
April 15, 2024
·
10 min read
Press Releases
Atara Biotherapeutics Provides Regulatory Updates on EBVALLO™ (tabelecleucel)
May 5, 2025
·
6 min read
Press Releases
Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support
April 23, 2025
·
12 min read
Press Releases
Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay
February 19, 2025
·
4 min read
1 of 70,580
Next
